Optimal Duration of Bismuth Quadruple Therapy for Helicobacter Pylori Eradication in Females As Compared with Males

NCT06509139 · clinicaltrials.gov ↗

PHASE4

Phase

ENROLLING_BY_INVITATION

Status

661

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori Infection
Sex
Bismuth Quadruple Therapy

Interventions

DRUG: Drug: Bismuth Subcitrate 120 MG Oral Tablet
DRUG: Esomeprazole 40mg
DRUG: Metronidazole 250 MG
DRUG: Tetracycline Pill

Sponsor

National Cheng-Kung University Hospital